AngioDynamics Action

AngioDynamics P/B

P/B (Ratio cours-valeur comptable) de AngioDynamics (ANGO) au 22 juil. 2026 est 2,47. L'année précédente, P/B (Ratio cours-valeur comptable) était 2,20 — une variation de 12,36 % (plus élevé).

P/B

2,47

YoY

12,36%

Dernière mise à jour:

P/B (Ratio cours-valeur comptable) de AngioDynamics est 2026 2,47 . P/B (Ratio cours-valeur comptable) de AngioDynamics était 2025 2,20 . Elle diminue ainsi de 12,36% plus élevé par rapport à l'année précédente.
Access this data via the Eulerpool API

AngioDynamics Analyse d'actions

Que fait AngioDynamics ? AngioDynamics Inc is a leading provider of medical devices and solutions for the treatment of vascular diseases and cancer. The company was founded in 1988 and is headquartered in Latham, New York. Over the years, AngioDynamics has evolved into a conglomerate through several acquisitions and partnerships, specializing in various areas. The key divisions include Vascular Access Solutions, Oncology Solutions, and Peripheral Vascular Solutions. AngioDynamics' focus is on developing and manufacturing innovative technologies that improve medical care and promote patient health. The company develops and distributes a wide range of medical devices and procedures to treat diseases such as cancer, venous diseases, and thrombosis. In the field of Vascular Access Solutions, AngioDynamics offers a wide range of devices for establishing vascular access, which are necessary in the treatment of serious illnesses. These include port systems and catheters that facilitate access to the body's vascular system. AngioDynamics' Oncology Solutions provide targeted cancer treatment solutions, including ultrasound-guided radiofrequency ablation systems and fusion biopsy systems. Developing innovative diagnostic and treatment options is a key focus of AngioDynamics. A large portion of AngioDynamics' products are in the area of Peripheral Vascular Solutions. Here, the company develops devices and procedures for the treatment of peripheral vascular diseases, such as varicosis or chronic venous insufficiency. This includes minimally invasive procedures such as laser and radiofrequency treatments. Due to its high-quality products, innovative technologies, and close collaboration with medical professionals, AngioDynamics has gained an excellent reputation in the medical industry. The company places great importance on providing optimal care to every patient and therefore serves hospitals, clinics, and medical practices worldwide. Throughout its years of existence, AngioDynamics has become a leading provider of medical devices and solutions for the treatment of vascular diseases and cancer. The company has built a broad customer base worldwide and has become an important player in the medical industry due to the quality and innovation of its products. AngioDynamics est l'une des entreprises les plus populaires sur Eulerpool.

Questions fréquemment posées sur l'action AngioDynamics

P/B (Ratio cours-valeur comptable) de AngioDynamics s'élève à 2,47 en 2026.

Access this data via the Eulerpool API

Valorisation — AngioDynamics

Toutes les Métriques Clés — AngioDynamics

Croissance